Association Briefs

Biotech Association To Aid Patent Office Frustrated with the Patent and Trademark Office’s multi-year delay in issuing biotechnology patents (see “Biotech Patent Bottleneck Harms Makers Of Better Mousetraps,” The Scientist, September 5, 1988, page 2), the Industrial Biotechnology Association has offered to help train patent examiners. ‘We decided not just to complain [about the backlog], but to do something about it,” IBA president Richard 0. Godown said October 2

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

Frustrated with the Patent and Trademark Office’s multi-year delay in issuing biotechnology patents (see “Biotech Patent Bottleneck Harms Makers Of Better Mousetraps,” The Scientist, September 5, 1988, page 2), the Industrial Biotechnology Association has offered to help train patent examiners. ‘We decided not just to complain [about the backlog], but to do something about it,” IBA president Richard 0. Godown said October 27 at IBA’s annual meeting in San Diego. The IBA, in conjunction with its member firms, will sponsor seminars on new developments in biotechnology, visits to industry labs, and lessons on specialized topics. The intent, according to Godown, “is to provide patent officers with the state of the art information they need to evaluate patent applications.” This, in turn, is expected to speed the patent examination process. Flushed with its success at the PTO, the IBA now intends to tackle the Food and Drug Administration. Godown is working ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies